Home » Country Reports » Mexico Digital PCR Market

Mexico Digital PCR Market By Type (Reagents and Consumables, Instruments, Software, Services, Others); By Application (Clinical Diagnostics, Research and Development, Environmental Testing, Forensic Testing, Others); By End-user (Hospitals and Clinics, Research Laboratories, Pharma and Biotech Companies, CROs and CDMOs, Others); By Technology (Droplet Digital PCR (ddPCR), BEAMing Digital PCR, Microwell Digital PCR); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Mexico Digital PCR Market Size 2023	USD 271.89 million
Mexico Digital PCR Market, CAGR	9.10%
Mexico Digital PCR Market Size 2032	USD 595.41 million

Market Overview

The Mexico Digital PCR Market is projected to grow from USD 271.89 million in 2023 to USD 595.41 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.10%.

The Mexico Digital PCR Market is driven by the increasing prevalence of chronic and infectious diseases, which necessitates accurate and sensitive diagnostic methods. The growing adoption of personalized medicine and advancements in molecular diagnostics are also propelling market growth. Additionally, government initiatives to improve healthcare infrastructure and investments in research and development are enhancing the availability and adoption of digital PCR technologies. The rising demand for precise and reliable diagnostic tools, coupled with technological advancements that offer high sensitivity and accuracy, are key trends shaping the Mexico Digital PCR Market, supporting its expansion across clinical and research applications.

The Mexico Digital PCR Market is primarily concentrated in urban centers such as Mexico City, Guadalajara, and Monterrey, where advanced healthcare facilities and research institutions drive demand for cutting-edge diagnostic technologies. These regions are hubs for clinical diagnostics and research activities, making them key markets for digital PCR applications. Leading players in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics, known for their extensive product portfolios and innovative digital PCR solutions. Other significant companies like Fluidigm Corporation, Qiagen, and Stilla Technologies also contribute to the competitive landscape, offering specialized digital PCR systems and reagents tailored to the needs of the Mexican market.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Advancements in Healthcare Infrastructure

Mexico is experiencing significant advancements in its healthcare infrastructure, which are facilitating the adoption of advanced diagnostic technologies like digital PCR. The expansion of well-equipped laboratories across the country is enabling healthcare providers to implement sophisticated testing methods that improve patient care. For instance, Mexico has seen enormous advances in its overall quality of public health in the last 50 years, with the number of medical units increasing from 7,938 in 1980 to 23,848 in 2018. Government initiatives aimed at strengthening healthcare infrastructure and enhancing diagnostic capabilities are also playing a crucial role in market growth. By investing in state-of-the-art laboratory equipment and technologies, the Mexican government is supporting the integration of digital PCR into routine clinical practice, thereby improving the overall quality of healthcare services.

Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases in Mexico, particularly cancer, is significantly driving the demand for digital PCR technologies. As cancer rates continue to climb, there is an increasing need for sensitive and accurate diagnostic tools that can detect cancer early and monitor its progression effectively. For instance, the World Health Organization reports that Mexico has a high prevalence of chronic diseases such as diabetes and ischemic heart disease, which threaten to decrease healthy life expectancy. Digital PCR offers high sensitivity, making it ideal for identifying low levels of genetic mutations associated with cancer. Similarly, Mexico’s high prevalence of infectious diseases, including HIV, hepatitis, and tuberculosis, necessitates reliable and precise testing methods. Digital PCR’s ability to detect and quantify low-abundance viral and bacterial DNA makes it a critical tool in managing these infectious diseases, ensuring accurate diagnosis and effective treatment.

Growing Focus on Precision Medicine

The increasing focus on precision medicine in Mexico is driving the adoption of digital PCR as a key tool for personalized treatment. Digital PCR’s capability to detect subtle genetic variations is essential for tailoring treatment plans to individual patients, thereby enhancing the effectiveness of therapies. The technology is also crucial for biomarker discovery and validation, which are fundamental to the development of targeted therapies. By enabling precise quantification of biomarkers, digital PCR supports the advancement of personalized medicine, offering more effective and tailored treatment options for patients with various diseases.

Technological Innovations and Academic Engagement

Technological innovations are transforming the digital PCR landscape, making the technology more accessible and efficient. The development of smaller, portable digital PCR devices is expanding the scope of applications, making them suitable for point-of-care testing and use in various clinical settings. Automation of digital PCR systems is streamlining laboratory workflows, reducing turnaround times, and increasing efficiency, which is critical for handling large volumes of samples in clinical laboratories. Additionally, academic and research activities in Mexico are driving market demand for digital PCR. Universities and research institutions are actively engaged in utilizing digital PCR for various research applications, and collaborations between academia and industry are fostering innovation and the development of new digital PCR products. These partnerships are crucial for advancing the field of molecular diagnostics and ensuring the continuous growth of the digital PCR market in Mexico.

Market Trends

Increasing Adoption in Clinical Diagnostics and Expanding Applications

The Mexico Digital PCR Market is experiencing significant growth due to the increasing adoption of digital PCR in clinical diagnostics. This technology is becoming essential for the early detection of various diseases, including cancer and infectious diseases, thereby leading to improved patient outcomes. For instance, a survey conducted by the International Journal of Pharmaceutical Research and Applications in June 2023 highlighted that digital PCR techniques are extensively applicable in investigating and assessing the relationship between an individual’s genetic makeup and its response to drugs. Digital PCR’s high sensitivity and accuracy allow for the detection of minute quantities of DNA, making it a valuable tool for early diagnosis. One notable application is in liquid biopsy, where digital PCR is used to analyze circulating tumor DNA. This non-invasive method is gaining traction for cancer diagnosis and monitoring, providing clinicians with critical information about tumor presence and genetic mutations without the need for invasive procedures. Beyond clinical diagnostics, digital PCR is finding expanding applications in other fields. In food safety, digital PCR is used to detect pathogens and genetically modified organisms, ensuring the safety and quality of food products.

Growing Preference for Point-of-Care Testing and Focus on Cost-Effective Solutions

There is a growing preference for point-of-care testing using digital PCR, driven by the need for rapid results and improved accessibility. The development of portable digital PCR devices is enabling testing to be conducted closer to patients, reducing turnaround times and facilitating timely decision-making. These portable devices allow healthcare providers to perform tests in various settings, such as clinics and remote locations, enhancing the reach and impact of diagnostic services. Point-of-care testing not only provides rapid results but also supports immediate clinical interventions, which are crucial in emergency and critical care scenarios. Furthermore, the market is seeing a strong focus on cost-effective solutions, with the introduction of more affordable digital PCR systems. Efforts are being made to reduce the cost of consumables, such as reagents and microfluidic chips, making digital PCR accessible to a broader range of healthcare providers, including smaller clinics and laboratories.

Market Challenges Analysis

Limited Healthcare Infrastructure and High Costs

The Mexico Digital PCR Market faces significant challenges related to limited healthcare infrastructure and high costs. In certain regions, there is a shortage of well-equipped laboratories capable of implementing advanced digital PCR technology. For instance, a survey by the Mexican Ministry of Health revealed that many rural areas lack the necessary facilities to support digital PCR testing, restricting its availability in underserved regions. Additionally, healthcare professionals may require further training to effectively utilize and interpret digital PCR results, which can be a barrier to adoption. For example, a report from a leading healthcare provider indicated that a significant number of their staff needed additional training to handle digital PCR equipment. The high initial investment required for digital PCR equipment and consumables is another major challenge, making it difficult for smaller laboratories and healthcare providers to access and implement this technology. The substantial costs associated with purchasing the equipment, along with the ongoing operational expenses for reagents and maintenance, pose a financial burden that can deter adoption. These cost factors make it challenging for many healthcare providers to integrate digital PCR into their diagnostic offerings, despite its potential benefits.

Regulatory Hurdles and Competition from Other Technologies

Navigating the complex regulatory landscape is another significant challenge for the Mexico Digital PCR Market. Obtaining approvals and complying with stringent quality standards can be time-consuming and costly, posing obstacles for companies seeking to introduce digital PCR technologies. Additionally, securing reimbursement for digital PCR tests from insurance providers remains a challenge, which can impact the widespread adoption of this technology. Without adequate reimbursement, healthcare providers may be hesitant to offer digital PCR tests, limiting their availability to patients. Furthermore, there is competition from other diagnostic technologies, such as real-time PCR, which may be preferred for certain applications due to familiarity and established use. The relative cost-effectiveness of digital PCR compared to alternative methods can influence adoption decisions, as some healthcare providers may opt for less expensive, albeit less sensitive, diagnostic tools. These challenges underscore the need for continuous innovation, education, and collaboration among stakeholders to overcome barriers and drive the adoption of digital PCR in the Mexican healthcare market. Addressing these hurdles will be crucial for ensuring that the benefits of digital PCR are realized and that it becomes a standard tool in diagnostic practices across the country.

Market Segmentation Analysis:

By Type:

The Mexico Digital PCR Market is segmented by type into reagents and consumables, instruments, software, services, and others. Reagents and consumables form a significant portion of the market, driven by the recurring need for these products in digital PCR workflows. These items are essential for the ongoing operation of digital PCR systems, leading to continuous demand. Instruments, which include digital PCR machines, represent another substantial segment, fueled by the growing adoption of advanced diagnostic technologies in clinical and research settings. The software segment is also expanding, as sophisticated data analysis and interpretation tools are crucial for maximizing the accuracy and efficiency of digital PCR results. Services, which include maintenance, calibration, and support, are becoming increasingly important as more laboratories and healthcare facilities adopt digital PCR technology. The ‘Others’ category covers additional products and services that support digital PCR applications, contributing to the overall growth and diversification of the market.

By Application:

Based on application, the Mexico Digital PCR Market is divided into clinical diagnostics, research and development, environmental testing, forensic testing, and others. Clinical diagnostics is the leading application segment, driven by the rising demand for precise and sensitive diagnostic tools for detecting and monitoring diseases such as cancer and infectious diseases. The ability of digital PCR to provide accurate quantification of nucleic acids makes it a preferred choice in clinical diagnostics. Research and development is another key segment, with academic and research institutions increasingly utilizing digital PCR for various molecular biology studies and genetic research. Environmental testing and forensic testing are emerging applications, where digital PCR is used for detecting pollutants, microorganisms, and for precise DNA analysis in criminal investigations. The ‘Others’ category includes niche applications where digital PCR technology can be applied, supporting the overall market expansion by catering to specific and diverse testing needs across different industries.

Segments:

Based on Type:

Reagents and Consumables
Instruments
Software
Services
Others

Based on Application:

Clinical Diagnostics
Research and Development
Environmental Testing
Forensic Testing
Others

Based on End-user:

Hospitals and Clinics
Research Laboratories
Pharma and Biotech Companies
CROs and CDMOs
Others

Based on Technology:

Droplet Digital PCR (ddPCR)
BEAMing Digital PCR
Microwell Digital PCR

Based on the Geography:

Northern region
Southern region
Pacific Coast region
Gulf Coast region
Yucatán Peninsula region
Western region
Eastern region

Regional Analysis

Northern region

In the Northern region, encompassing states like Nuevo León, Coahuila, and Chihuahua, digital PCR companies command a substantial market share of approximately 40%. This dominance is largely attributed to the region’s robust healthcare infrastructure, strong ties with U.S. biotechnology firms, and a concentration of research-intensive universities. Northern Mexico’s digital PCR market thrives on applications in precision medicine, particularly in oncology and rare genetic disorders. The region’s proximity to the U.S. border facilitates rapid adoption of cutting-edge digital PCR technologies and fosters collaborations with international research institutions. Northern Mexico’s digital PCR sector also leads in developing high-throughput screening methods for industrial and environmental applications, capitalizing on the region’s diverse manufacturing base.

Western region

The Western region, including states such as Jalisco, Guanajuato, and Michoacán, holds a growing market share of about 30% in the digital PCR sector. This area has witnessed significant growth in biotechnology and life sciences industries over recent years, driven by government initiatives to establish innovation hubs and attract foreign investment. The Western region’s digital PCR market distinguishes itself through a focus on agrobiotechnology and food safety applications, leveraging the area’s strong agricultural and food processing sectors. Digital PCR firms in this region excel in developing assays for detecting foodborne pathogens, authenticating premium food products, and monitoring genetically modified organisms in crops. The market in Western Mexico also sees increasing adoption of digital PCR in the expanding pharmaceutical and medical device manufacturing sectors, particularly for quality control and contamination monitoring.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Thermo Fisher Scientific
Bio-Rad Laboratories
Stilla Technologies
RainDance Technologies (acquired by Bio-Rad)
Fluidigm Corporation
Roche Diagnostics
SABiosciences (now part of Qiagen)
Jiangsu Aibio Diagnostics Co., Ltd.
Genomic Vision
Qiagen
GeneCure Biotechnologies
Eppendorf
Agilent Technologies
PerkinElmer
Nanosphere (acquired by Luminex)

Competitive Analysis

The Mexico Digital PCR Market is highly competitive, with leading players such as Thermo Fisher Scientific, Bio-Rad Laboratories, Stilla Technologies and Roche Diagnostics setting the standard through their advanced technologies and comprehensive product offerings. These companies are recognized for their innovation in digital PCR systems, providing high sensitivity and accuracy needed for clinical diagnostics and research applications. They also offer extensive support services, enhancing their market position. These companies emphasize technological advancements and user-friendly systems to differentiate themselves in the market. The presence of these established firms drives continuous innovation and improvement in digital PCR technologies, ensuring that they meet the evolving demands of healthcare providers and research institutions, thus maintaining a robust and competitive market environment in Mexico.

Recent Developments

In April 2024, Bio-Rad Laboratories launched its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit.
In July 2024, Bio-Rad outlined its advances leveraging Droplet Digital PCR in biopharma and translational research sectors.
In June 2024, Qiagen launched 35 new wet-lab tested digital PCR Microbial DNA Detection Assays for its digital PCR platform QIAcuity.
In June 2024, Stilla Technologies expanded its product portfolio with two new digital PCR configurations for the Nio™ product line.
In November 2023, Roche launched the LightCycler PRO System, an advanced qPCR technology for clinical diagnostics and research.

Market Concentration & Characteristics

The Mexico Digital PCR Market exhibits moderate to high market concentration, dominated by a few key players such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics. These companies have established strong market positions due to their extensive product portfolios, advanced technological capabilities, and comprehensive support services. They cater to the growing demand for precise diagnostic tools across clinical, research, and environmental applications. Market concentration is further influenced by the presence of other notable players like Fluidigm Corporation, Qiagen, and Stilla Technologies, which focus on niche segments and specialized applications. The market is characterized by a strong emphasis on innovation, with companies continuously developing new digital PCR platforms that offer improved sensitivity, accuracy, and ease of use. The competitive landscape encourages these firms to invest heavily in research and development, ensuring that their products meet the rigorous standards required for clinical diagnostics and research, thus maintaining a dynamic and evolving market environment in Mexico.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-user, Technology and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Mexico Digital PCR Market is expected to grow significantly due to the increasing demand for precise and reliable diagnostic tools.
Technological advancements in digital PCR will continue to enhance sensitivity, accuracy, and ease of use.
The adoption of digital PCR for liquid biopsy applications will increase, driven by the need for non-invasive cancer diagnostics.
Government initiatives to improve healthcare infrastructure will support the expansion of digital PCR technologies.
The rising prevalence of infectious diseases will drive demand for accurate diagnostic solutions, boosting the market.
More affordable digital PCR systems will become available, making the technology accessible to a broader range of healthcare providers.
Point-of-care digital PCR testing will gain traction, offering rapid and convenient diagnostic solutions.
Partnerships and collaborations between academic institutions and industry players will foster innovation and product development.
Increased focus on environmental monitoring and food safety testing will open new application areas for digital PCR.
Training programs and educational initiatives will be essential to build expertise and drive adoption of digital PCR technology in clinical and research settings.

CHAPTER NO. 1 : INTRODUCTION 16

1.1.1. Report Description 16

Purpose of the Report 16

USP & Key Offerings 16

1.1.2. Key Benefits for Stakeholders 16

1.1.3. Target Audience 17

1.1.4. Report Scope 17

CHAPTER NO. 2 : EXECUTIVE SUMMARY 18

2.1. Digital PCR Market Snapshot 18

2.1.1. Mexico Digital PCR Market, 2018 – 2032 (USD Million) 19

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 20

3.1. Russia-Ukraine and Israel-Palestine War Impacts 20

CHAPTER NO. 4 : DIGITAL PCR MARKET – INDUSTRY ANALYSIS 21

4.1. Introduction 21

4.2. Market Drivers 22

4.2.1. Driving Factor 1 Analysis 22

4.2.2. Driving Factor 2 Analysis 23

4.3. Market Restraints 24

4.3.1. Restraining Factor Analysis 24

4.4. Market Opportunities 25

4.4.1. Market Opportunity Analysis 25

4.5. Porter’s Five Forces Analysis 26

4.6. Value Chain Analysis 27

4.7. Buying Criteria 28

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 29

5.1. Import Analysis by Mexico 29

5.1.1. Mexico Digital PCR Market Import Volume/Revenue, By Mexico, 2018 – 2023 29

5.2. Export Analysis by Mexico 30

5.2.1. Mexico Digital PCR Market Export Volume/Revenue, By Mexico, 2018 – 2023 30

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 31

6.1. Demand Analysis by Mexico 31

6.1.1. Mexico Digital PCR Market Demand Volume/Revenue, By Mexico, 2018 – 2023 31

6.2. Supply Analysis by Mexico 32

6.2.1. Mexico Digital PCR Market Supply Volume/Revenue, By Mexico, 2018 – 2023 32

CHAPTER NO. 7 : PRODUCTION ANALYSIS 33

7.1. Production Analysis by Mexico 33

7.1.1. Mexico Digital PCR Market Production Volume/Revenue, By Mexico, 2018 – 2023 33

CHAPTER NO. 8 : PRICE ANALYSIS 34

8.1. Price Analysis by Type 34

8.1.1. Mexico Digital PCR Market Price, By Type, 2018 – 2023 34

8.1.2. Mexico Type Market Price, By Type, 2018 – 2023 34

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 35

9.1. Key Raw Materials and Suppliers 35

9.2. Key Raw Materials Price Trend 35

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 36

10.1. Manufacturing Cost Analysis 36

10.2. Manufacturing Process 36

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 37

11.1. Company Market Share Analysis – 2023 37

11.1.1. Mexico Digital PCR Market: Company Market Share, by Volume, 2023 37

11.1.2. Mexico Digital PCR Market: Company Market Share, by Revenue, 2023 38

11.1.3. Mexico Digital PCR Market: Top 6 Company Market Share, by Revenue, 2023 38

11.1.4. Mexico Digital PCR Market: Top 3 Company Market Share, by Revenue, 2023 39

11.2. Mexico Digital PCR Market Company Revenue Market Share, 2023 40

11.3. Company Assessment Metrics, 2023 41

11.3.1. Stars 41

11.3.2. Emerging Leaders 41

11.3.3. Pervasive Players 41

11.3.4. Participants 41

11.4. Start-ups /SMEs Assessment Metrics, 2023 41

11.4.1. Progressive Companies 41

11.4.2. Responsive Companies 41

11.4.3. Dynamic Companies 41

11.4.4. Starting Blocks 41

11.5. Strategic Developments 42

11.5.1. Acquisitions & Mergers 42

New Product Launch 42

Mexico Expansion 42

11.6. Key Players Product Matrix 43

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 44

12.1. PESTEL 44

12.1.1. Political Factors 44

12.1.2. Economic Factors 44

12.1.3. Social Factors 44

12.1.4. Technological Factors 44

12.1.5. Environmental Factors 44

12.1.6. Legal Factors 44

12.2. Adjacent Market Analysis 44

CHAPTER NO. 13 : DIGITAL PCR MARKET – BY TYPE SEGMENT ANALYSIS 45

13.1. Digital PCR Market Overview, by Type Segment 45

13.1.1. Digital PCR Market Revenue Share, By Type, 2023 & 2032 46

13.1.2. Digital PCR Market Attractiveness Analysis, By Type 47

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 47

13.1.4. Digital PCR Market Revenue, By Type, 2018, 2023, 2027 & 2032 48

13.2. Reagents and Consumables 49

13.3. Instruments 50

13.4. Software 51

13.5. Services 52

13.6. Others 53

CHAPTER NO. 14 : DIGITAL PCR MARKET – BY APPLICATION SEGMENT ANALYSIS 54

14.1. Digital PCR Market Overview, by Application Segment 54

14.1.1. Digital PCR Market Revenue Share, By Application, 2023 & 2032 55

14.1.2. Digital PCR Market Attractiveness Analysis, By Application 56

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 56

14.1.4. Digital PCR Market Revenue, By Application, 2018, 2023, 2027 & 2032 57

14.2. Clinical Diagnostics 58

14.3. Research and Development 59

14.4. Environmental Testing 60

14.5. Forensic Testing 61

14.6. Others 62

CHAPTER NO. 15 : DIGITAL PCR MARKET – BY END-USER SEGMENT ANALYSIS 63

15.1. Digital PCR Market Overview, by End-user Segment 63

15.1.1. Digital PCR Market Revenue Share, By End-user, 2023 & 2032 64

15.1.2. Digital PCR Market Attractiveness Analysis, By End-user 65

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 65

15.1.4. Digital PCR Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

15.2. Hospitals and Clinics 67

15.3. Research Laboratories 68

15.4. Pharma and Biotech Companies 69

15.5. CROs and CDMOs 70

15.6. Others 71

CHAPTER NO. 16 : DIGITAL PCR MARKET – BY TECHNOLOGY SEGMENT ANALYSIS 72

16.1. Digital PCR Market Overview, by Technology Segment 72

16.1.1. Digital PCR Market Revenue Share, By Technology, 2023 & 2032 73

16.1.2. Digital PCR Market Attractiveness Analysis, By Technology 74

16.1.3. Incremental Revenue Growth Opportunity, by Technology, 2024 – 2032 74

16.1.4. Digital PCR Market Revenue, By Technology, 2018, 2023, 2027 & 2032 75

16.2. Droplet Digital PCR (ddPCR) 76

16.3. BEAMing Digital PCR 77

16.4. Microwell Digital PCR 78

CHAPTER NO. 17 : DIGITAL PCR MARKET – MEXICO ANALYSIS 79

17.1. Type 79

17.1.1. Mexico Digital PCR Market Revenue, By Type, 2018 – 2023 (USD Million) 79

17.2. Mexico Digital PCR Market Revenue, By Type, 2024 – 2032 (USD Million) 79

17.3. Application 80

17.3.1. Mexico Digital PCR Market Revenue, By Application, 2018 – 2023 (USD Million) 80

17.3.2. Mexico Digital PCR Market Revenue, By Application, 2024 – 2032 (USD Million) 80

17.4. End-user 81

17.4.1. Mexico Digital PCR Market Revenue, By End-user, 2018 – 2023 (USD Million) 81

17.4.2. Mexico Digital PCR Market Revenue, By End-user, 2024 – 2032 (USD Million) 81

17.5. Technology 82

17.5.1. Mexico Digital PCR Market Revenue, By Technology, 2018 – 2023 (USD Million) 82

17.5.2. Mexico Digital PCR Market Revenue, By Technology, 2024 – 2032 (USD Million) 82

CHAPTER NO. 18 : COMPANY PROFILES 83

18.1. Thermo Fisher Scientific 83

18.1.1. Company Overview 83

18.1.2. Product Portfolio 83

18.1.3. Swot Analysis 83

18.1.4. Business Strategy 84

18.1.5. Financial Overview 84

18.1.6. Bio-Rad Laboratories. 85

18.1.7. Stilla Technologies 85

18.1.8. RainDance Technologies (acquired by Bio-Rad) 85

18.1.9. Fluidigm Corporation 85

18.1.10. Roche Diagnostics 85

18.1.11. SABiosciences (now part of Qiagen) 85

18.1.12. Jiangsu Aibio Diagnostics Co., Ltd. 85

18.1.13. Genomic Vision 85

18.1.14. Qiagen 85

18.1.15. GeneCure Biotechnologies 85

18.1.16. Eppendorf 85

18.1.17. Agilent Technologies 85

18.1.18. PerkinElmer 85

18.1.19. Nanosphere (acquired by Luminex) 85

CHAPTER NO. 19 : RESEARCH METHODOLOGY 86

19.1. Research Methodology 86

19.1.1. Phase I – Secondary Research 87

19.1.2. Phase II – Data Modeling 87

Company Share Analysis Model 88

Revenue Based Modeling 88

19.1.3. Phase III – Primary Research 89

19.1.4. Research Limitations 90

Assumptions 90

List of Figures

FIG NO. 1. Mexico Digital PCR Market Revenue, 2018 – 2032 (USD Million) 19

FIG NO. 2. Porter’s Five Forces Analysis for Mexico Digital PCR Market 26

FIG NO. 3. Value Chain Analysis for Mexico Digital PCR Market 27

FIG NO. 4. Mexico Digital PCR Market Import Volume/Revenue, By Mexico, 2018 – 2023 29

FIG NO. 5. Mexico Digital PCR Market Export Volume/Revenue, By Mexico, 2018 – 2023 30

FIG NO. 6. Mexico Digital PCR Market Demand Volume/Revenue, By Mexico, 2018 – 2023 31

FIG NO. 7. Mexico Digital PCR Market Supply Volume/Revenue, By Mexico, 2018 – 2023 32

FIG NO. 8. Mexico Digital PCR Market Production Volume/Revenue, By Mexico, 2018 – 2023 33

FIG NO. 9. Mexico Digital PCR Market Price, By Type, 2018 – 2023 34

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 35

FIG NO. 11. Manufacturing Cost Analysis 36

FIG NO. 12. Manufacturing Process 36

FIG NO. 13. Company Share Analysis, 2023 37

FIG NO. 14. Company Share Analysis, 2023 38

FIG NO. 15. Company Share Analysis, 2023 38

FIG NO. 16. Company Share Analysis, 2023 39

FIG NO. 17. Digital PCR Market – Company Revenue Market Share, 2023 40

FIG NO. 18. Digital PCR Market Revenue Share, By Type, 2023 & 2032 46

FIG NO. 19. Market Attractiveness Analysis, By Type 47

FIG NO. 20. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 47

FIG NO. 21. Digital PCR Market Revenue, By Type, 2018, 2023, 2027 & 2032 48

FIG NO. 22. Mexico Digital PCR Market for Reagents and Consumables, Revenue (USD Million) 2018 – 2032 49

FIG NO. 23. Mexico Digital PCR Market for Instruments, Revenue (USD Million) 2018 – 2032 50

FIG NO. 24. Mexico Digital PCR Market for Software, Revenue (USD Million) 2018 – 2032 51

FIG NO. 25. Mexico Digital PCR Market for Services, Revenue (USD Million) 2018 – 2032 52

FIG NO. 26. Mexico Digital PCR Market for Others, Revenue (USD Million) 2018 – 2032 53

FIG NO. 27. Digital PCR Market Revenue Share, By Application, 2023 & 2032 55

FIG NO. 28. Market Attractiveness Analysis, By Application 56

FIG NO. 29. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 56

FIG NO. 30. Digital PCR Market Revenue, By Application, 2018, 2023, 2027 & 2032 57

FIG NO. 31. Mexico Digital PCR Market for Clinical Diagnostics, Revenue (USD Million) 2018 – 2032 58

FIG NO. 32. Mexico Digital PCR Market for Research and Development, Revenue (USD Million) 2018 – 2032 59

FIG NO. 33. Mexico Digital PCR Market for Environmental Testing, Revenue (USD Million) 2018 – 2032 60

FIG NO. 34. Mexico Digital PCR Market for Forensic Testing, Revenue (USD Million) 2018 – 2032 61

FIG NO. 35. Mexico Digital PCR Market for Others, Revenue (USD Million) 2018 – 2032 62

FIG NO. 36. Digital PCR Market Revenue Share, By End-user, 2023 & 2032 64

FIG NO. 37. Market Attractiveness Analysis, By End-user 65

FIG NO. 38. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 65

FIG NO. 39. Digital PCR Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

FIG NO. 40. Mexico Digital PCR Market for Hospitals and Clinics, Revenue (USD Million) 2018 – 2032 67

FIG NO. 41. Mexico Digital PCR Market for Research Laboratories, Revenue (USD Million) 2018 – 2032 68

FIG NO. 42. Mexico Digital PCR Market for Pharma and Biotech Companies, Revenue (USD Million) 2018 – 2032 69

FIG NO. 43. Mexico Digital PCR Market for CROs and CDMOs, Revenue (USD Million) 2018 – 2032 70

FIG NO. 44. Mexico Digital PCR Market for Others, Revenue (USD Million) 2018 – 2032 71

FIG NO. 45. Digital PCR Market Revenue Share, By Technology, 2023 & 2032 73

FIG NO. 46. Market Attractiveness Analysis, By Technology 74

FIG NO. 47. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 74

FIG NO. 48. Digital PCR Market Revenue, By Technology, 2018, 2023, 2027 & 2032 75

FIG NO. 49. Mexico Digital PCR Market for Droplet Digital PCR (ddPCR), Revenue (USD Million) 2018 – 2032 76

FIG NO. 50. Mexico Digital PCR Market for BEAMing Digital PCR, Revenue (USD Million) 2018 – 2032 77

FIG NO. 51. Mexico Digital PCR Market for Microwell Digital PCR, Revenue (USD Million) 2018 – 2032 78

FIG NO. 52. Research Methodology – Detailed View 86

FIG NO. 53. Research Methodology 87

List of Tables

TABLE NO. 1. : Mexico Digital PCR Market: Snapshot 18

TABLE NO. 2. : Drivers for the Digital PCR Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the Digital PCR Market: Impact Analysis 24

TABLE NO. 4. : Mexico Digital PCR Market Revenue, By Type, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : Mexico Digital PCR Market Revenue, By Type, 2018 – 2023 (USD Million) 79

TABLE NO. 7. : Mexico Digital PCR Market Revenue, By Type, 2024 – 2032 (USD Million) 79

TABLE NO. 8. : Mexico Digital PCR Market Revenue, By Application, 2018 – 2023 (USD Million) 80

TABLE NO. 9. : Mexico Digital PCR Market Revenue, By Application, 2024 – 2032 (USD Million) 80

TABLE NO. 10. : Mexico Digital PCR Market Revenue, By End-user, 2018 – 2023 (USD Million) 81

TABLE NO. 11. : Mexico Digital PCR Market Revenue, By End-user, 2024 – 2032 (USD Million) 81

TABLE NO. 12. : Mexico Digital PCR Market Revenue, By Technology, 2018 – 2023 (USD Million) 82

TABLE NO. 13. : Mexico Digital PCR Market Revenue, By Technology, 2024 – 2032 (USD Million) 82

Frequently Asked Questions:

What is the current size of the Mexico Digital PCR Market?

The Mexico Digital PCR Market is projected to grow from USD 271.89 million in 2023 to USD 595.41 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.10%.

What factors are driving the growth of the Mexico Digital PCR Market?

The growth of the Mexico Digital PCR Market is driven by the increasing prevalence of chronic and infectious diseases, the growing adoption of personalized medicine, and advancements in molecular diagnostics. Government initiatives to improve healthcare infrastructure and investments in research and development are also enhancing the availability and adoption of digital PCR technologies, supporting market expansion.

What are the key segments within the Mexico Digital PCR Market?

The key segments of the Mexico Digital PCR Market include type and application. By type, the market is segmented into reagents and consumables, instruments, software, services, and others. Based on application, the market is divided into clinical diagnostics, research and development, environmental testing, forensic testing, and others, each serving different diagnostic and research needs.

Who are the major players in the Mexico Digital PCR Market?

Major players in the Mexico Digital PCR Market include Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics. Other significant companies such as Fluidigm Corporation, Qiagen, and Stilla Technologies also contribute to the competitive landscape, offering specialized digital PCR systems and reagents tailored to the needs of the Mexican market.

Purchase Options

Single User

$1699

Multi User

$2699

Enterprise

$3699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –